To further analyze the consequences of sarcomeric transcript deregulation and establish a link between Bru-3 function and DM1, we focused on Actn, a conserved sarcomeric target of Bru-3/CELF1. The gene discussed is CELF1; the disease is myotonic dystrophy type 1.